Status:
UNKNOWN
Sarcopenic Obesity: Estimation of Prevalence and Identification of Clinical and Biological Determinants in a Population of Adult Obese Patients
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Obesity
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This project aims first to determine the prevalence of sarcopenia in a population of obese people of extended age group (18-70 years). In a second step, the factors determining and / or predisposing t...
Detailed Description
Collection of clinical and paraclinical data (biological and anthropometric) for evaluation of sarcopenic obesity in obese patients. Biological collection to identify plasma, serum, genetic, urinary ...
Eligibility Criteria
Inclusion
- Age: 18-70 years
- Sex: men and women
- Patient followed in clinical nutrition benefiting from a metabolic assessment for optimization of clinical and paraclinical management
- Patient meeting the criteria of obesity defined by BMI\> 30 kg / m²
- Major patient with free, informed and signed consent
- Patient covered by the social security scheme
Exclusion
- Patient with cancer or severe chronic disease (renal failure, respiratory failure, liver failure)
- Patient with neuromuscular disease
- Patient with a total inability to walk
- Minor patient
- Refusal of the patient to participate in the study
- Pregnant or lactating women
- Patient deprived of liberty or under guardianship.
Key Trial Info
Start Date :
June 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 6 2020
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT03394469
Start Date
June 4 2018
End Date
June 6 2020
Last Update
February 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003